Flow cytometry results showed a lower CD276 expression on tumor xenografts-derived Rh4 cells, with a fluorescence intensity 14-fold higher than the control, compared to cultured Rh4 cells (600-fold over control) (Fig. 15A). Here, CD276 is linked to neoplasm.